Christopher Bolten, an esteemed Intellectual Property (IP) and tech attorney with a focus on medical technology, has been appointed a shareholder at Greenberg Traurig’s Life Sciences and Medical Technology Practice in San Diego, as reported on May 24, 2024.
With significant experience in the legal aspects of medical technology, Bolten is known for his comprehensive approach to help medical device and digital health firms across the United States, Europe, and Israel. His work mainly involves building protective patent portfolios and providing rigorous enforcement of his clients’ IP rights, earning him quite a reputation in the IP law domain.
Additionally, Bolten offers due diligence services for IP to venture capital firms intending to invest in the medical technology sector. This process aids in identifying and mitigating potential investment risks, thereby playing a crucial role in decision making for venture capitalists.
Prior to joining Greenberg Traurig, Bolten held his practice at Eversheds Sutherland, bringing a wealth of experience and a wide skill set to his new role.
Firms such as Greenberg Traurig are continually on the lookout for seasoned professionals like Bolten, whose intricate understanding of the IP domain combined with his specialized knowledge in the medical tech industry, can offer clients value-added, targeted legal advice. Increasingly, we are witnessing a market trend where domain-specific expertise is highly prized, and this move signifies Greenberg Traurig’s commitment to that end.
Details of this development have been initially reported by Bloomberg Law.